Boehringer Ingelheim gets USFDA Breakthrough Therapy designation for survodutide Ruchika Sharma8 Oct 2024 3:59 PM ISTBoehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI...
Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio Ruchika Sharma5 Sept 2024 2:30 PM ISTBoehringer Ingelheim acquires Saiba Animal Health, strengthens animal health RnD pipelineIngelheim: Boehringer Ingelheim has said it has acquired...
Boehringer Ingelheim: Shashank Deshpande to lead Human Pharma business unit, Carinne Brouillon to retire MD Bureau Team2 Sept 2024 2:38 PM ISTIngelheim: Boehringer Ingelheim has announced that Shashank Deshpande, member of the Board of Managing Directors with responsibility for the Animal...
Pfizer Chief Scientific Officer Dr Mikael Dolsten to depart Ruchika Sharma10 July 2024 2:30 PM ISTNew York: Pfizer Inc. has announced that Dr. Mikael Dolsten, Pfizer's Chief Scientific Officer and President, Pfizer Research & Development,...
GlaxoSmithKline Pharma appoints Dr Shalini Menon as Executive Vice President - Medical Affairs Ruchika Sharma5 July 2024 4:53 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has appointed Dr. Shalini Menon as Executive Vice President - Medical Affairs, effective 8th...
Zantac not a cause of woman's cancer, says jury Ruchika Sharma24 May 2024 3:34 PM ISTChicago: A jury in Chicago delivered a verdict on Thursday, dismissing the claim of an Illinois woman who alleged that the discontinued...
Boehringer Ingelheim Spevigo injection for generalized pustular psoriasis flares gets CDSCO nod Ruchika Sharma18 May 2024 2:30 PM ISTMumbai: The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim's SPEVIGO (spesolimab) injection, a...
Walgreens, Boehringer Ingelheim partner to improve diversity in clinical trials Ruchika Sharma5 May 2024 10:00 AM ISTDeerfield: Walgreens and Boehringer Ingelheim have announced a strategic collaboration aimed at optimizing recruitment and making clinical trials...
Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases Ruchika Sharma2 May 2024 11:30 AM ISTThe high-concentration formulation (100 mg/mL), which is now available as a pre-filled syringe or pre-filled autoinjector.
India becoming attractive for clinical trials: Pharma industry leaders Ruchika Sharma29 April 2024 2:33 PM ISTNew Delhi: Experts from the pharmaceutical sector have noted that over the last decade, clinical trials in India have undergone significant...
Boehringer Ingelheim, Sosei Heptares collaborate to develop first-in-class treatments targeting all symptoms of schizophrenia Ruchika Sharma11 March 2024 9:00 AM ISTIngelheim: Boehringer Ingelheim and Sosei Group Corporation have announced they have entered a global collaboration and exclusive...
Boehringer Ingelheim accused of misusing US patents to delay asthma-drug rivals Ruchika Sharma7 March 2024 12:38 PM ISTGerman drugmaker Boehringer Ingelheim was accused in a federal lawsuit in Boston on Wednesday of improperly submitting patents to the U.S. Food and...
